|
|
Article: New data from Y. Neuzillet et al illuminate research in renal cell carcinoma prognosis.
- Article from:
- Angiogenesis Weekly
- Article date:
- November 20, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
A report, 'Prognostic factors for cases with metastatic renal cell carcinoma in the era of targeted medicine,' is newly published data in International Journal of Urology. According to a study from Suresnes, France, "Prognostic factors in the setting of treated metastatic renal cell carcinoma (mRCC) can theoretically predict drug response, progression-free survival or overall survival. These factors are potentially useful for informing patients and for tailoring medical treatment according to risk assessment."
"Prognostic factors were well defined in the era of immunotherapy. Since 2006, tyrosine kinase inhibitors and anti-angiogenic drugs have revolutionized the ...